Eris Ipo Grey Market

Eris ipo grey market

Eris Lifesciences Limited IPO IPO Details

Issue Date16/06 - 20/06
Issue SizeRs.

About Eris Lifesciences Limited IPO IPO

1741.16 Cr

Issue PriceRs. 600-603
Market Lot24 Shares
Shares on Offer28,875,000
Registrar
GMPRs.73-76
KostakRs.300
Subject to SaudaN/A
Listing Date29/06
Listing PriceRs.612
Listing Gain%1.49

About Eris Lifesciences Limited IPO IPO

Eris Lifesciences founded by Mr Amit Bakshi and team in 2007 is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market such as: cardiovascular; anti–diabetes; vitamins; gastroenterology and gynaecology.

Their focus has been on developing, manufacturing and marketing products which are linked to lifestyle related disorders that are chronic in nature and are treated by superspecialist and specialist doctors.

They have a team of over 2287 employees across India as on September 30, 2016. Their specialty field force consists of 1300+ medical representatives and 612 field managers.

IPO Grey Market Premium, Latest IPO GMP & Kostak Rates

Their teams at the manufacturing facility and corporate office together comprise of 365 employees.

Eris features amongst the Top 30 companies in the Indian Branded Formulations Market.

Their core commitment is towards improving health care outcomes and adding value for all our stakeholders including patients, doctors, regulators, employees and business partners.

They aim to become most admired company by doctors, patients, employees and all channel partners.

They are committed to patients and doctors as users of our products; we will strive to do our best at every step of the chain by providing best of the products and services.

They will make ongoing efforts to innovate our products to bring the best clinical practices in health care industry to our customers.

They will conduct ourselves with high integrity to ensure respect of our colleagues is maintained and their excellence is recognized; they aspire to provide best of compensation and career opportunities to our colleagues.

Incorporated in 2007, Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris product portfolio is primarily focused on therapeutic areas which require the intervention of super specialist and specialist doctors such as Diabetologists, Endocrinologists Cardiologists, and Gastroenterologists.

Eris products in the chronic category cater primarily to the therapeutic areas including cardiovascular, anti-diabetics and neurology, chronic respiratory and chronic pain (analgesics).

In acute category, the product portfolio includes vitamins, gastroenterology, anti-infectives, gynaecology, cute respiratory, acute pain (analgesics), hepatoprotectives, hormones, hematology, dermatology, anti-obesity products and products for injury healing.

Eris Lifescience own and operate a manufacturing facility in Guwahati, Assam.

They also outsource the manufacturing of certain of its products to 20 manufacturers. Eris strong sales team comprised of 1,310 marketing representatives.

Eris Lifesciences Limited IPO - Subscription Details

Eris Lifesciences Limited IPO - Company Financials

Eris Lifesciences Limited IPO - Allotment Status

Please click the link below to check the IPO allotment status.

IPO Allotment Status

Eris Lifesciences Limited IPO IPO Reviews

  • We don't recommend subscription of Eris Lifesciences Limited IPO.

Eris Lifesciences Limited IPO IPO FAQs

  1. When will Eris Lifesciences Limited IPO IPO open?

    Eris Lifesciences Limited IPO IPO will open on 16/06 and close on 20/06.

  2. What is the listing date of Eris Lifesciences Limited IPO IPO?

    Eris Lifesciences Limited IPO IPO will list on 29/06.

  3. What is the offer price of Eris Lifesciences Limited IPO IPO?

    The offer price of Eris Lifesciences Limited IPO IPO is Rs.600-603.

  4. What is the lot size of Eris Lifesciences Limited IPO IPO?

    The lot size of Eris Lifesciences Limited IPO IPO is 24.

  5. What is the Grey Market Premium (GMP) price of Eris Lifesciences Limited IPO IPO?

    The Grey Market Premium (GMP) price of Eris Lifesciences Limited IPO IPO is Rs.73-76.

  6. What is the Kostak price of Eris Lifesciences Limited IPO IPO?

    The Kostak price of Eris Lifesciences Limited IPO IPO is Rs.300.

  7. What is the Subject to Sauda price for Eris Lifesciences Limited IPO IPO?

    The Subject to Sauda price for Eris Lifesciences Limited IPO IPO is Not Available at the moment.

NSE and BSE IPO grey market Premium - What you need to know

The grey market - or, the illegal premium market for initial public offerings (IPOs) was back after almost a decade.

After its death almost 10 years ago, the the grey market was reborn in August, 2004 with Tata Consultancy Services (TCS) Ltd issue.

It is a completely illegal market where stocks are traded even before allotments in the IPOs are made.

In fact, the unofficial trading begins well before the scrip is listed.

The transaction in this market is normally between parties who know each other very well.

They trade in scrips unofficially and settle accounts outside of the stock exchanges once the allotments by the companies are decided.

Normally, third parties are not part of such trading.

However, a third party is entertained only if he is introduced through a person known in the circuit.

Two parties agree to settle the trade at a price on the day of listing through the stock market mechanism and the difference is settled through cash, explained broking industry sources.

A robust secondary market has aided this trend and players in this segment are doing brisk business across centres.

Eris ipo grey market

Ahmedabad is the most active grey market centre while Kolkata, Delhi and Mumbai are also some of the centres where grey market for IPOs is alive and kicking.

A dealer with a brokerage house said, The future of the grey market for the IPOs is linked with the robustness of the secondary market. Till the time the cash market is in the pink of health, this grey market will flourish and the moment a downturn is signalled in the cash market, the grey market downturn will be faster than that of the cash market.

Swing trading with options book

In such an event, the premium market will disappear altogether.

IPO grey market - Glossary

  1. IPO - IPO is an initial public offering (IPO) is the first time that the stock of a private company is offered to the public.

    IPOs are often issued by smaller, younger companies seeking capital to expand, but they can also be done by large privately owned companies looking to become publicly traded.

    IPO Grey Market Discussion

  2. IPO Grey Market - A grey market (sometimes called a parallel market, but this can also mean other things; not to be confused with a blackmarket or a grey economy) is the trade of a commodity through distribution channels that are legal but unintended by the original manufacturer.
  3. GMP - GMP is Grey market premium (or grey market price) is a premium amount in rupees at which IPO shares are being traded in Grey Market before they get listed in stock exchange.

    Grey market premium can be in positive or in negative based on demand and supply of the stock.

    Forex factory called james 16 group

    Grey Market Premiums are also attached with words 'Buyer' or 'Seller'. They tell the price either at which buyers are willing to buy shares or the price at which sellers are willing to sell their IPO shares.

  4. Kostak - Kostak (or price of application) is the premium amount in rupees at which IPO applications are being traded in IPO Grey Market.

    Eris LifeSciences IPO: Brokerage Views & Runup to IPO

    Usually 'Kostak' value is defined as the premium of a maximum lot retail application in an IPO. Kostak price is important mostly before issue is close for subscription and final bidding status is available to the IPO investors. Very few IPOs applications are traded after final bidding status is available to the investors.

    Eris ipo grey market

    'Kostak' is especially for people who do not want to take risk with IPO allotment or listing gains.

  5. Basis of IPO allotment - In August 2012 SEBI has made regressive changes in the allotment procedures.

    As per these changes, every retail applicant will get a certain number of shares, though it is subject to the availability.

    Mainline IPOs in 2020

    It clearly means that retail investors are now assured to get minimum number of shares at a decided ratio irrespective of the lots they have applied, subject to availability.

    However remaining shares will be allotted proportionately. Current procedure is quite encouraging for retail investors as now they have assurance of getting shares in IPO. As per this practice every investor has equal probability of getting shares in an IPO irrespective of the lots he applied in an oversubscribed issue.

    What is Grey Market Premium?

    Even if he applied for minimum permissible lot he may get minimum number of stocks allotted to shareholders. In fact retail investors who apply for smaller lots may have a better chance of getting more number of shares than the investors who applies for maximum amount permissible.

    Eris ipo grey market

Date & TimeQIBNIIRIITotal
Day 1 - June 16,20170.070.020.410.12
Day 2 - June 19,20170.820.031.680.75
Day 3 - June 20,20174.680.453.513.29
Particulars31-Mar-1631-Mar-1531-Mar-1431-Mar-1331-Mar-12
Total Assets (In Rs.

Millions)

3,973.593,572.852,705.991,718.051,019.67
Total Revenue (In Rs.

Eris ipo grey market

Millions)

5,970.215,455.585,088.223,930.642,739.40
Profit After Tax (PAT) (In Rs. Millions)1,348.58892.59709.12584.40370.63